Selective ophthalmic artery chemotherapy with melphalan shows promise for retinoblastoma

Phase 2 results show that selective ophthalmic artery chemotherapy with melphalan can be used as a first-line therapy for retinoblastoma.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553